Rakuten Investment Management’s Charles River Laboratories CRL Stock Holding History

Rakuten Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,389	Closed	-$892K	–	515
2025 Q4	$892K	Sell	4,389 -72,667	-94%	-$13.2M	﹤0.01%	521
2025 Q3	$3.02M	Buy	+77,056	New	+$12.2M	0.01%	331
2025 Q1	$508K	Buy	+3,263	New	+$547K	﹤0.01%	563
2024 Q3	$580K	Buy	2,923 +732	+33%	+$152K	﹤0.01%	419
2024 Q2	$454K	Buy	2,191 +812	+59%	+$184K	﹤0.01%	407
2024 Q1	$374K	Buy	1,379 +1,252	+986%	+$299K	﹤0.01%	377
2023 Q4	$30.3K	Buy	+127	New	+$25K	﹤0.01%	381

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rakuten Investment Management's CRL Position: Q1 2026 in Review

Rakuten Investment Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 4,389 shares — an estimated $892K sold.

Rakuten Investment Management first reported a position in CRL in Q4 2023 and held it in 7 quarters. The position peaked at $3.02M in Q3 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Rakuten Investment Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Rakuten Investment Management sold 4,389 Charles River Laboratories shares in Q1 2026, an estimated $892K.
Rakuten Investment Management first reported a position in Charles River Laboratories in Q4 2023 and held it in 7 quarters.
Rakuten Investment Management's Charles River Laboratories position peaked at $3.02M in Q3 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.